Company intelligence / Profile preview

Cook Imaging

Bloomington, Indiana, United States

Ownership: Private
Development stage: Other

Overview

Cook Imaging was a pharmaceutical company based in Bloomington, Indiana, that specialized in the development and manufacture of contrast media for diagnostic imaging. As a subsidiary of the Cook Group, the company focused on providing high-quality radiopaque agents to improve the visualization of internal structures during medical procedures. Its primary product, Oxilan (ioxilan), is a non-ionic contrast medium used extensively in computed tomography and angiography. In 2001, Cook Imaging was acquired by Mallinckrodt, a division of Tyco Healthcare, which integrated the business into its global imaging operations.

Therapeutic areas: CardiovascularOther
Modalities: Small molecule
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Cook Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cook Imaging.

Explore the full profile